STOCK TITAN
  1. Home
  2. Sec-filings
  3. HUM
  4. [Form 4] HUMANA INC Insider Trading Activity

Humana (HUM) director Raquel Bono discloses new deferred stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Humana Inc. director Raquel C. Bono reported equity awards and deferrals. The filing shows she acquired 766 restricted stock units as part of her annual director fee, which she elected to receive in stock units rather than cash. These units are deferred until she resigns from the board, at which time they will be settled in Humana common shares on a one-for-one basis under the company’s 2019 Amended & Restated Plan.

She also reported 34 additional stock units from dividend payments that were reinvested on already vested and deferred stock units. These dividend units are likewise deferred until she leaves board service and will then be paid in Humana common stock on a one-for-one basis.

Positive

  • None.

Negative

  • None.
Insider Bono Raquel C.
Role Director
Type Security Shares Price Value
Grant/Award Restricted Stock Units 766 $0.00 --
Grant/Award Restricted Stock Units 34 $258.8675 $9K
holding Humana Common -- -- --
Holdings After Transaction: Restricted Stock Units — 3,174 shares (Direct); Humana Common — 397 shares (Direct)
Footnotes (1)
  1. Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bono Raquel C.
(Last) (First) (Middle)
HUMANA INC.
101 E. MAIN STREET
(Street)
LOUISVILLE KY 40202
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HUMANA INC [ HUM ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Humana Common 397 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units(1) (1) 01/02/2026 A 766 (1) (1) Humana Common 766 $0 3,174(1) D
Restricted Stock Units(2) (2) 12/31/2025 A 34 (2) (2) Humana Common 34 $258.8675 72 D
Explanation of Responses:
1. Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.
2. Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
Raquel C. Bono 01/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Humana (HUM) director Raquel C. Bono report in this Form 4?

The Form 4 reports that director Raquel C. Bono acquired 766 restricted stock units as part of her annual director fee and 34 additional stock units from the reinvestment of dividend payments on vested and deferred stock units.

How will the 766 restricted stock units reported by Humana (HUM) be settled?

The 766 restricted stock units represent a contingent right to receive one share of Humana Inc. common stock per unit, payable after Dr. Bono resigns from service as a director, under the company’s 2019 Amended & Restated Plan.

When will the deferred stock units for Humana (HUM) director Raquel C. Bono be paid?

Both the annual director fee stock units and the dividend reinvestment stock units are deferred until her resignation as a director, at which time they will be payable in Humana Inc. common stock on a 1-for-1 basis.

Under what rules are Humana (HUM) director stock units treated for reporting purposes?

The annual director fee stock units and related restricted stock units are described as exempt pursuant to Rule 16(b)-3(d)(1) under the company’s equity plan, reflecting how these board compensation awards are treated under Section 16 rules.